283 related articles for article (PubMed ID: 10354396)
1. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Vinson JA; Bose P; Iannone A; Staffieri M; Antolini L; Del Corso A; Mura U; Albasini A
J Med Chem; 1999 Jun; 42(11):1881-93. PubMed ID: 10354396
[TBL] [Abstract][Full Text] [Related]
2. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 2'-oxo-2,3-dihydro-3'H- spiro[chromene-4,5'-[1,3]oxazolidin]-3'yl]acetic acid derivatives as aldose reductase inhibitors.
Rapposelli S; Da Settimo F; Digiacomo M; La Motta C; Lapucci A; Sartini S; Vanni M
Arch Pharm (Weinheim); 2011 Jun; 344(6):372-85. PubMed ID: 21319207
[TBL] [Abstract][Full Text] [Related]
5. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Giovannoni MP; Dal Piaz V; Vianello P; Barlocco D
J Med Chem; 1999 Jun; 42(11):1894-900. PubMed ID: 10354397
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
[TBL] [Abstract][Full Text] [Related]
7. Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.
La Motta C; Sartini S; Mugnaini L; Simorini F; Taliani S; Salerno S; Marini AM; Da Settimo F; Lavecchia A; Novellino E; Cantore M; Failli P; Ciuffi M
J Med Chem; 2007 Oct; 50(20):4917-27. PubMed ID: 17845019
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
[TBL] [Abstract][Full Text] [Related]
9. On the synthesis of bioisosters of o-benzothiazolyloxybenzoic acids and evaluation as aldose reductase inhibitors.
Rakowitz D; Muigg P; Schröder N; Matuszczak B
Arch Pharm (Weinheim); 2005 Sep; 338(9):419-26. PubMed ID: 16143958
[TBL] [Abstract][Full Text] [Related]
10. Curcumin analogs as potent aldose reductase inhibitors.
Du ZY; Bao YD; Liu Z; Qiao W; Ma L; Huang ZS; Gu LQ; Chan AS
Arch Pharm (Weinheim); 2006 Mar; 339(3):123-8. PubMed ID: 16528793
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel benzoic acid derivatives with benzothiazolyl subunit and evaluation as aldose reductase inhibitors.
Rakowitz D; Hennig B; Nagano M; Steger S; Costantino L; Matuszczak B
Arch Pharm (Weinheim); 2005 Sep; 338(9):411-8. PubMed ID: 16143954
[TBL] [Abstract][Full Text] [Related]
12. Spirohydantoin derivatives of thiopyrano[2,3-b]pyridin-4(4H)-one as potent in vitro and in vivo aldose reductase inhibitors.
Da Settimo F; Primofiore G; La Motta C; Salerno S; Novellino E; Greco G; Lavecchia A; Laneri S; Boldrini E
Bioorg Med Chem; 2005 Jan; 13(2):491-9. PubMed ID: 15598571
[TBL] [Abstract][Full Text] [Related]
13. Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.
Juskova M; Majekova M; Demopoulos V; Stefek M
Gen Physiol Biophys; 2011 Dec; 30(4):342-9. PubMed ID: 22131315
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
15. Acid derivatives of benzisothiazole-1,1-dioxide as inhibitors of rat lens aldose reductase.
Da Settimo A; Primofiore G; La Motta C; Da Settimo F; Simorini F; Boldrini E; Bianchini P
Farmaco; 1996 Apr; 51(4):261-7. PubMed ID: 8645413
[TBL] [Abstract][Full Text] [Related]
16. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R
Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophor requirements of the aldose reductase inhibitor site.
Kador PF; Sharpless NE
Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
Costantino L; Rastelli G; Vescovini K; Cignarella G; Vianello P; Del Corso A; Cappiello M; Mura U; Barlocco D
J Med Chem; 1996 Oct; 39(22):4396-405. PubMed ID: 8893834
[TBL] [Abstract][Full Text] [Related]
20. Highly selective aldose reductase inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Ishii A; Kotani T; Nagaki Y; Shibayama Y; Toyomaki Y; Okukado N; Ienaga K; Okamoto K
J Med Chem; 1996 Apr; 39(9):1924-7. PubMed ID: 8627616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
